These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

420 related items for PubMed ID: 1912580

  • 1. In vivo production of interleukin-5, granulocyte-macrophage colony-stimulating factor, macrophages colony-stimulating factor, and interleukin-6 during intravenous administration of high-dose interleukin-2 in cancer patients.
    Schaafsma MR, Falkenburg JH, Landegent JE, Duinkerken N, Osanto S, Ralph P, Kaushansky K, Wagemaker G, Van Damme J, Willemze R.
    Blood; 1991 Oct 15; 78(8):1981-7. PubMed ID: 1912580
    [Abstract] [Full Text] [Related]

  • 2. Immune effects of escalating doses of granulocyte-macrophage colony-stimulating factor added to a fixed, low-dose, inpatient interleukin-2 regimen: a randomized phase I trial in patients with metastatic melanoma and renal cell carcinoma.
    Smith II JW, Kurt RA, Baher AG, Denman S, Justice L, Doran T, Gilbert M, Alvord WG, Urba WJ.
    J Immunother; 2003 Oct 15; 26(2):130-8. PubMed ID: 12616104
    [Abstract] [Full Text] [Related]

  • 3. Cytokine regulation of colony-stimulating factor production in cultured human synovial fibroblasts: I. Induction of GM-CSF and G-CSF production by interleukin-1 and tumor necrosis factor.
    Leizer T, Cebon J, Layton JE, Hamilton JA.
    Blood; 1990 Nov 15; 76(10):1989-96. PubMed ID: 1700731
    [Abstract] [Full Text] [Related]

  • 4. Activities of granulocyte-macrophage colony-stimulating factor and interleukin-3 on monocytes.
    Suzuki H, Katayama N, Ikuta Y, Mukai K, Fujieda A, Mitani H, Araki H, Miyashita H, Hoshino N, Nishikawa H, Nishii K, Minami N, Shiku H.
    Am J Hematol; 2004 Apr 15; 75(4):179-89. PubMed ID: 15054806
    [Abstract] [Full Text] [Related]

  • 5. Hematopoietic recovery following high-dose combined alkylating-agent chemotherapy and autologous bone marrow support in patients in phase-I clinical trials of colony-stimulating factors: G-CSF, GM-CSF, IL-1, IL-2, M-CSF.
    Laughlin MJ, Kirkpatrick G, Sabiston N, Peters W, Kurtzberg J.
    Ann Hematol; 1993 Dec 15; 67(6):267-76. PubMed ID: 7506580
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Secretion of GM-CSF and M-CSF by human renal cell carcinomas of different histologic types.
    Gerharz CD, Reinecke P, Schneider EM, Schmitz M, Gabbert HE.
    Urology; 2001 Nov 15; 58(5):821-7. PubMed ID: 11711375
    [Abstract] [Full Text] [Related]

  • 11. Production of granulocyte colony-stimulating factor and granulocyte/macrophage-colony-stimulating factor after interleukin-1 stimulation of marrow stromal cell cultures from normal or aplastic anemia donors.
    Migliaccio AR, Migliaccio G, Adamson JW, Torok-Storb B.
    J Cell Physiol; 1992 Jul 15; 152(1):199-206. PubMed ID: 1377699
    [Abstract] [Full Text] [Related]

  • 12. Interleukin-10 inhibits spontaneous colony-forming unit-granulocyte-macrophage growth from human peripheral blood mononuclear cells by suppression of endogenous granulocyte-macrophage colony-stimulating factor release.
    Oehler L, Foedinger M, Koeller M, Kollars M, Reiter E, Bohle B, Skoupy S, Fritsch G, Lechner K, Geissler K.
    Blood; 1997 Feb 15; 89(4):1147-53. PubMed ID: 9028936
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
    Tso CL, Zisman A, Pantuck A, Calilliw R, Hernandez JM, Paik S, Nguyen D, Gitlitz B, Shintaku PI, de Kernion J, Figlin R, Belldegrun A.
    Cancer Res; 2001 Nov 01; 61(21):7925-33. PubMed ID: 11691814
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Potentiating effect of granulocyte-macrophage colony-stimulating factor on interleukin-1-induced thymocyte proliferation: evidence for an interleukin-2 and tumor necrosis factor-independent pathway.
    Herbelin A, Machavoine F, Dy M.
    Lymphokine Res; 1990 Nov 01; 9(2):155-65. PubMed ID: 2187117
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Interleukin-1 synergizes with granulocyte-macrophage colony-stimulating factor on granulocytic colony formation by intermediate production of granulocyte colony-stimulating factor.
    Schaafsma MR, Falkenburg JH, Duinkerken N, Van Damme J, Altrock BW, Willemze R, Fibbe WE.
    Blood; 1989 Nov 15; 74(7):2398-404. PubMed ID: 2478229
    [Abstract] [Full Text] [Related]

  • 19. Interleukin 1 and poly(rI).poly(rC) induce production of granulocyte CSF, macrophage CSF, and granulocyte-macrophage CSF by human endothelial cells.
    Fibbe WE, Daha MR, Hiemstra PS, Duinkerken N, Lurvink E, Ralph P, Altrock BW, Kaushansky K, Willemze R, Falkenburg JH.
    Exp Hematol; 1989 Mar 15; 17(3):229-34. PubMed ID: 2465167
    [Abstract] [Full Text] [Related]

  • 20. Cytokine regulation of granulocyte-macrophage colony stimulating factor and macrophage colony-stimulating factor production in human arterial smooth muscle cells.
    Filonzi EL, Zoellner H, Stanton H, Hamilton JA.
    Atherosclerosis; 1993 Mar 15; 99(2):241-52. PubMed ID: 8503951
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.